Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Kapusta Matthew C | CEO, CFO, Managing Director | Dec 16 | Option Exercise | 7.53 | 12,501 | 94,133 | 277,738 | Dec 21 08:12 AM | Kapusta Matthew C | CEO, CFO, Managing Director | Dec 16 | Sale | 48.41 | 12,501 | 605,173 | 265,237 | Dec 21 08:12 AM | Kapusta Matthew C | CEO, CFO, Managing Director | Nov 19 | Option Exercise | 7.53 | 3,125 | 23,531 | 276,592 | Nov 24 04:25 PM | Kapusta Matthew C | CEO, CFO, Managing Director | Nov 19 | Sale | 45.18 | 11,355 | 513,019 | 265,237 | Nov 24 04:25 PM | Kapusta Matthew C | CEO, CFO, Managing Director | Nov 18 | Option Exercise | 7.53 | 3,216 | 24,216 | 283,780 | Nov 20 04:58 PM | Kapusta Matthew C | CEO, CFO, Managing Director | Nov 18 | Sale | 43.69 | 10,313 | 450,579 | 273,467 | Nov 20 04:58 PM | Kapusta Matthew C | CEO, CFO, Managing Director | Oct 14 | Sale | 35.86 | 5,250 | 188,256 | 280,564 | Oct 16 04:10 PM | Gut Robert | Chief Medical Officer | Sep 21 | Sale | 39.12 | 4,352 | 170,250 | 41,523 | Sep 22 09:48 AM | Kuta Alexander Edward III | Executive VP, Operations | Sep 18 | Sale | 41.18 | 2,230 | 91,831 | 56,860 | Sep 22 09:54 AM | Kapusta Matthew C | CEO, CFO, Managing Director | Sep 16 | Sale | 40.66 | 7,500 | 304,939 | 285,814 | Sep 18 01:41 PM | Kapusta Matthew C | CEO, CFO, Managing Director | Aug 25 | Sale | 40.27 | 300 | 12,081 | 293,314 | Aug 27 05:00 PM | Kapusta Matthew C | CEO, CFO, Managing Director | Aug 19 | Sale | 39.11 | 4,300 | 168,175 | 293,614 | Aug 21 04:32 PM | Kapusta Matthew C | CEO, CFO, Managing Director | Jul 22 | Sale | 42.31 | 5,626 | 238,025 | 297,914 | Jul 24 04:41 PM | Gut Robert | Chief Medical Officer | Jun 23 | Option Exercise | 39.12 | 26,875 | 1,051,344 | 72,750 | Jun 24 04:21 PM | Gut Robert | Chief Medical Officer | Jun 23 | Sale | 70.00 | 26,875 | 1,881,250 | 45,875 | Jun 24 04:21 PM | Kapusta Matthew C | CEO, CFO, Managing Director | Jun 17 | Sale | 66.04 | 7,501 | 495,366 | 303,540 | Jun 22 04:43 PM | Kapusta Matthew C | CEO, CFO, Managing Director | May 20 | Sale | 59.94 | 7,501 | 449,580 | 311,041 | May 22 05:13 PM | KLEMT CHRISTIAN | Chief Accounting Officer | Apr 24 | Option Exercise | 26.41 | 2,250 | 59,423 | 59,268 | Apr 28 04:29 PM | KLEMT CHRISTIAN | Chief Accounting Officer | Apr 24 | Sale | 60.00 | 2,250 | 135,000 | 57,018 | Apr 28 04:29 PM | Kapusta Matthew C | CEO, CFO, Managing Director | Apr 22 | Option Exercise | 7.53 | 9,376 | 70,601 | 327,918 | Apr 24 04:46 PM | Kapusta Matthew C | CEO, CFO, Managing Director | Apr 22 | Sale | 56.87 | 9,376 | 533,205 | 318,542 | Apr 24 04:46 PM | Kapusta Matthew C | CEO, CFO, Managing Director | Mar 18 | Option Exercise | 7.53 | 5,626 | 42,364 | 324,168 | Mar 20 01:16 PM | Kapusta Matthew C | CEO, CFO, Managing Director | Mar 18 | Sale | 41.48 | 5,626 | 233,352 | 318,542 | Mar 20 01:16 PM | KLEMT CHRISTIAN | Chief Accounting Officer | Mar 04 | Option Exercise | 26.41 | 15,750 | 415,958 | 72,768 | Mar 06 10:07 AM | KLEMT CHRISTIAN | Chief Accounting Officer | Mar 04 | Sale | 52.29 | 15,750 | 823,500 | 57,018 | Mar 06 10:07 AM | Kapusta Matthew C | CEO, CFO, Managing Director | Feb 19 | Sale | 64.56 | 7,501 | 484,256 | 284,753 | Feb 21 10:03 AM | Soteropoulos Paula | Director | Feb 05 | Sale | 60.95 | 2,122 | 129,332 | 2,423 | Feb 05 01:19 PM | Kapusta Matthew C | CEO, CFO, Managing Director | Jan 31 | Sale | 57.98 | 3,872 | 224,499 | 264,541 | Jan 31 03:45 PM | Astley-Sparke Philip | Director | Jan 30 | Sale | 59.23 | 807 | 47,799 | 6,005 | Jan 30 09:39 PM | Kapusta Matthew C | CEO, CFO, Managing Director | Jan 30 | Sale | 59.31 | 23,583 | 1,398,646 | 268,413 | Jan 31 03:45 PM | Kapusta Matthew C | CEO, CFO, Managing Director | Jan 29 | Sale | 61.94 | 23,583 | 1,460,794 | 291,996 | Jan 31 03:45 PM | Kaye Jack | Director | Jan 28 | Sale | 62.20 | 806 | 50,133 | 14,128 | Jan 30 09:32 PM | Balachandran Madhavan | Director | Jan 28 | Sale | 62.20 | 807 | 50,195 | 6,005 | Jan 30 09:23 PM | Soteropoulos Paula | Director | Jan 28 | Sale | 62.19 | 807 | 50,187 | 4,545 | Jan 30 09:15 PM | van Deventer Sander | EVP, Research & Product Dev. | Jan 28 | Sale | 61.61 | 2,227 | 137,214 | 43,127 | Jan 30 09:11 PM | SCHAFFER DAVID | Director | Jan 28 | Sale | 62.27 | 806 | 50,190 | 44,915 | Jan 30 09:06 PM | KLEMT CHRISTIAN | Chief Accounting Officer | Jan 28 | Sale | 61.47 | 11,975 | 736,072 | 42,564 | Jan 30 09:02 PM | Springhorn Jeremy P. | Director | Jan 28 | Sale | 62.19 | 807 | 50,190 | 6,005 | Jan 30 08:57 PM | Meek David D. | Director | Jan 28 | Sale | 62.19 | 722 | 44,903 | 2,508 | Jan 30 08:54 PM | Gut Robert | Chief Medical Officer | Jan 28 | Sale | 62.19 | 596 | 37,065 | 27,885 | Jan 29 06:02 PM | Kuta Alexander Edward III | Executive VP, Operations | Jan 28 | Sale | 62.14 | 1,478 | 91,848 | 40,100 | Jan 30 09:36 PM | Kapusta Matthew C | CEO, CFO, Managing Director | Jan 28 | Sale | 61.92 | 23,583 | 1,460,221 | 315,579 | Jan 29 11:24 AM | Kapusta Matthew C | CEO, CFO, Managing Director | Jan 27 | Sale | 65.55 | 28,289 | 1,854,280 | 339,162 | Jan 29 11:24 AM | Gut Robert | Chief Medical Officer | Jan 27 | Sale | 60.01 | 6,897 | 413,889 | 28,481 | Jan 29 06:02 PM |
|